David Statman is an Editorial Features Manager at Healio. With a background in sports journalism, he has transitioned into medical publishing, bringing his storytelling expertise to health-related topics. Statman has been recognized with multiple awards from the West Virginia Press Association and has been featured in Healio and TALL PINES HEALTHCARE, INC.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
David Statman focuses on medical research, particularly in the healthcare and pharmaceutical sectors. His articles are data-driven, often citing specific studies or clinical trials. He would likely be interested in receiving pitches related to new scientific findings, breakthroughs in medical treatments or therapies, and insights from experts involved in these areas.
Given his strong emphasis on citing data and press releases, he is more inclined towards evidence-based information rather than speculative content. Pitches should center around concrete scientific discoveries or developments within the specified medical conditions and treatments mentioned in his article titles.
While there isn't a specified geographic focus for David's coverage, it seems that the topics he covers have global relevance. Therefore, relevant pitches could come from experts or organizations worldwide who can provide valuable insights into these particular areas of medical research.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The family of a California woman won a $32 million judgment after she developed mesothelioma from Johnson & Johnson talc-based baby powder.
A new study by the Sylvester Cancer Center showed that overall mesothelioma rates have fallen since 1990, although progress has been uneven.
Surgeons from Stanford University made history with the first-ever PITAC procedure to treat pleural mesothelioma.
The House of Representatives passed a bill that could provide benefit increases for veterans with service-related mesothelioma.
The EPA announced that it is delaying its planned new asbestos protection rule until 2027, citing the need for more information about its health risk.
Results from a British study on mesothelioma recommended that caregivers give a greater focus on treating pain as a symptom of the disease.
Researchers published a study showing pemetrexed and platinum is effective as a second-line pleural mesothelioma treatment.
The UK department store chain John Lewis issued a recall of a 15 products due to asbestos contamination, including doorstops and draught excluders.
Researchers at the University of Vermont published results showing promising data for a new PRX3 inhibitor in mesothelioma treatment.
An Illinois court upheld a $45 million verdict against Johnson & Johnson for a woman who died of mesothelioma.
